Advertisement

Topics

Excision BioTherapeutics Exclusively Licenses New CRISPR-Cas Gene Editors from UC Berkeley, to ...

10:01 EST 13 Nov 2017 | BioMedReports - Blog

In February of 2017, Drs. Jennifer Doudnaand Jillian Banfieldpublished a paper in Nature, indicating the discovery of new CRISPR-Cas systems from uncultivated

Read more...

Original Article: Excision BioTherapeutics Exclusively Licenses New CRISPR-Cas Gene Editors from UC Berkeley, to ...

NEXT ARTICLE

More From BioPortfolio on "Excision BioTherapeutics Exclusively Licenses New CRISPR-Cas Gene Editors from UC Berkeley, to ..."

Advertisement
Quick Search
Advertisement
Advertisement